Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $75.0 million.

  • Oncology Institute's Shares Outstanding (Weighted Average) rose 2906.33% to $97.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 2906.33%. This contributed to the annual value of $75.0 million for FY2024, which is 175.6% up from last year.
  • According to the latest figures from FY2024, Oncology Institute's Shares Outstanding (Weighted Average) is $75.0 million, which was up 175.6% from $73.7 million recorded in FY2023.
  • Oncology Institute's Shares Outstanding (Weighted Average)'s 5-year high stood at $75.0 million during FY2024, with a 5-year trough of $59.1 million in FY2020.
  • In the last 5 years, Oncology Institute's Shares Outstanding (Weighted Average) had a median value of $72.8 million in 2022 and averaged $69.4 million.
  • Per our database at Business Quant, Oncology Institute's Shares Outstanding (Weighted Average) surged by 1203.17% in 2021 and then surged by 131.22% in 2023.
  • Oncology Institute's Shares Outstanding (Weighted Average) (Annual) stood at $59.1 million in 2020, then rose by 12.03% to $66.2 million in 2021, then rose by 9.91% to $72.8 million in 2022, then rose by 1.31% to $73.7 million in 2023, then increased by 1.76% to $75.0 million in 2024.
  • Its Shares Outstanding (Weighted Average) was $75.0 million in FY2024, compared to $73.7 million in FY2023 and $72.8 million in FY2022.